EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

2 hedge funds and large institutions have $35.8K invested in Eagle Pharmaceuticals, Inc. in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SLG
1
Stanley-Laman Group
Pennsylvania
$34.8K
AIC
2
Archer Investment Corporation
Indiana
$1.01K